20/20 Biolabs, Inc. Common Stock (AIDX)

NASDAQ Healthcare Medical - Devices

20/20 GeneSystems, Inc. operates as a specialized clinical diagnostic company, focusing primarily on screening for cancer and analyzing viral infections. The firm offers advanced blood tests for the early detection of various cancers, including a notable product called OneTest. Additionally, it provides services for identifying viruses, such as rapid COVID-19 test kits like the Assure COVID-19 IgG/IgM rapid assay. The company also manages the Clinical Lab Innovation Axcelerator (CLIAx), a collaborative laboratory space designed to help developers of diagnostic products bring their innovations …